The Effect of Switch Treatment on Liver Fibrosis and qHBsAg Levels in Patients with Chronic Hepatitis B

Yesilyurt, Esra; Kaya, Muhammed; Dindar, Gokhan; Acikgoz, Seyyid; Guzelbulut, Fatih; Sezikli, Hayrunnisa; Şirin, GÖKTUĞ; Sezikli, Mesut

doi:10.4274/vhd.galenos.2020.2020.0008

The Effect of Switch Treatment on Liver Fibrosis and qHBsAg Levels in Patients with Chronic Hepatitis B

Yesilyurt E., Kaya M., Dindar G., Acikgoz S. B., Guzelbulut F., Sezikli H., ...More

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.26, pp.69-73, 2020 (ESCI, TRDizin)

Publication Type: Article / Article
Volume: 26
Publication Date: 2020
Doi Number: 10.4274/vhd.galenos.2020.2020.0008
Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Page Numbers: pp.69-73
Kocaeli University Affiliated: Yes

Abstract

Objectives: The aim of this study was to evaluate the relationship between clinical, biochemical, serological parameters, fibroscan imaging in terms of fibrosis and quantitative hepatitis B surface antigen (qHBsAg) levels in patients with chronic hepatitis B (CHB) infection whose treatment has been switched from LAM to TDF.